| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 6 Feb 2026 | 29 Jan 2026 |
| Uniphos Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 inter alia to consider and approve We wish to inform you pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Reg. 2015 that a Meeting of the Board of Directors of the Company is scheduled to be held on Friday the 6th February 2026 inter-alia to consider and approve the Unaudited Financial Results of the Co. for the quarter and nine months ended 31st December 2025 and take on record limited review report on unaudited financial results to be issued by M/s. B S R & Co. LLP Chartered Accountants Statutory Auditor of the Co. Further as intimated earlier vide our letter dated 31st December 2025 as per the SEBI (PIT) Reg. 2015 the Trading Window Close Period for all Designated Persons has commenced from 1st January 2026 and will continue till completion of 48 hours after the Unaudited Financial Results of the Company for the quarter and nine months ended 31st Dec. 2025 is uploaded online on the portal of the Stock Exchanges where the securities of the Company are listed. Please find attached Unaudited Financial Results for the quarter and nine months ended 31st December, 2025 (As Per BSE Announcement Dated on:06.02.2026) | ||
| Board Meeting | 11 Nov 2025 | 3 Nov 2025 |
| Uniphos Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended 30th September 2025 and take on record limited review report on unaudited financial results to be issued by M/s. B S R & Co. LLP Chartered Accountants Statutory Auditor of the Company. Further as intimated earlier vide our letter dated 30th September 2025 as per the SEBI (Prevention of Insider Trading) Regulations 2015 the Trading Window Close Period for all Designated Persons has commenced from 1st October 2025 and will continue till completion of 48 hours after the Unaudited Financial Results of the Company for the quarter and half year ended 30th September 2025 is uploaded online on the portal of the Stock Exchanges where the securities of the Company are listed. Please find attached Unaudited Financial Results for the quarter and half year ended 30th September, 2025. (As Per Bse Announcement dated on 11/11/2025) | ||
| Board Meeting | 13 Aug 2025 | 5 Aug 2025 |
| Uniphos Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended 30th June 2025 and take on record limited review report on unaudited financial results to be issued by M/s. B S R & Co. LLP Chartered Accountants Statutory Auditor of the Company. Further as intimated earlier vide our letter dated 30th June 2025 as per the SEBI (Prevention of Insider Trading) Regulations 2015 the Trading Window Close Period for all Designated Persons has commenced from 1st July 2025 and will continue till completion of 48 hours after the Unaudited Financial Results of the Company for the quarter ended 30th June 2025 is uploaded online on the portal of the Stock Exchanges where the securities of the Company are listed. Please find attached Unaudited Financial Results for the quarter ended 30th June, 2025 (As Per BSE Announcement Dated on: 13.08.2025) | ||
| Board Meeting | 28 May 2025 | 20 May 2025 |
| Uniphos Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 inter alia to consider and approve 1. The Audited Financial Results of the Company for the quarter and financial year ended 31st March 2025 and to take on record audit report on audited financial results to be issued by M/s. B S R & Co. LLP Chartered Accountants Statutory Auditor of the Company. 2. Recommendation of dividend if any on the equity shares of the Company for the financial year ending 31st March 2025 subject to approval of the shareholders at the ensuing Annual General Meeting. Please find attached Audited Financial Results for the quarter and year ended 31st March, 2025 Recommended dividend of t0.50 or paise 50 (i.e., 25%) per equity share on equity shares of face value of t2/- each for the financial year ended 31 st March, 2025, subject to deduction of tax at source and approval of members at the ensuing 56 th Annual General Meeting (AGM). The dividend will be paid to the shareholders within 30 days of the AGM. Please find attached Audited Financial Results for the quarter and year ended 31st March, 2025 (As Per BSE Announcement Dated on 28.05.2025) | ||
| Board Meeting | 28 Mar 2025 | 28 Mar 2025 |
| Please find attached letter dated 28th March, 2025 with regard to appointment of Mrs. Sandra Rajnikant Shroff (DIN: 00189012) as Managing Director for five years w.e.f. 1st April, 2025 and cessation of Mr. Rajnikant Devidas Shroff (DIN: 00180810) as Managing Director on completion of his term on 31st March, 2025. | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
